Skip to main content
Caplight Logo









Esper Bionics

Esper Bionics

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.esperbionics.com/

Last Round

VC Round

Jun 27, 2024

Total Funding Raised

$2.37M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Esper Bionics is a healthtech company that develops an AI-powered bionic ecosystem, including robotic limb prostheses and controllers for individuals with limb differences.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Application

Keywords

bionic handmyoelectric prostheticbionic armai-powered prostheticssmart prosthesisupper-limb prostheticsbionicsEMG sensorselectromyographyorthotics and prostheticsO&Pmedical devicehealth iotmedical aiwearable technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Esper Bionics Comparables

Compare Esper Bionics with similar companies based on industry and business-model similarity.

Esper Bionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BionIT Labs
89%
BrainRobotics
88%
COVVI
88%

Esper Bionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 27, 2024
GrantMay 17, 2024
GrantAug 26, 2022
AcceleratorOct 5, 2021
SeedSep 3, 2020
Grant
Apr 18, 2019

Key People

Founding team and executive leadership

Dima Gazda

Founder, CEO

Founding Team

Kyrylo Perevozchykov

Chief Technology Officer

Executive Team

Halyna Tahiyeva

Chief Financial Officer

Executive Team

Vitalii Sahan

CPO (Sensors)

Executive Team

Esper Bionics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 58% MoM.

  • Sep 3, 2020

    Raised $2M from Newlab, SMRK VC Fund, and Alchemist Accelerator.

Esper Bionics Filings

Explore SEC and related filing metadata, where available.

Esper Bionics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Esper Bionics's valuation, stock price, and market status.

Is Esper Bionics a public or private company?

Esper Bionics is a private company.

What is the current stock price of Esper Bionics?

Esper Bionics is a private company with no public stock price. No recent secondary market data is available.

How much is Esper Bionics worth (valuation)?

Valuation information for Esper Bionics is not publicly available.

Can I buy Esper Bionics stock?

Esper Bionics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Esper Bionics's last funding round?

Esper Bionics's most recent funding round was Series A on June 28, 2024.

Who are the main investors in Esper Bionics?

Key investors in Esper Bionics include YZR Capital.

Will Esper Bionics IPO soon?

No public IPO plans have been announced for Esper Bionics.

How can I track Esper Bionics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Esper Bionics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range61
Year Founded2019
Last FundingJun 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?